Stability of extemporaneously prepared glycopyrrolate oral suspensions

Cober, Mary Petrea; Johnson, Cary E.; Sudekum, David; Penprase, Kimberly
May 2011
American Journal of Health-System Pharmacy;5/1/2011, Vol. 68 Issue 9, p843
Academic Journal
Purpose. The stability of extemporaneously prepared glycopyrrolate 0.5-mg/mL suspensions was evaluated. Methods. An oral suspension of glycopyrrolate 0.5 mg/mL was prepared by thoroughly grinding 30 1-mg tablets of glycopyrrolate in a glass mortar. Thirty milliliters of Ora-Plus and 30 mL of either Ora-Sweet or Ora-Sweet SF were mixed and added to the powder to make a final volume of 60 mL. Three identical samples of the formulation were prepared and placed in 2-oz amber plastic bottles with child-resistant caps and stored at room temperature (23-25 °C). A 1-mL sample was withdrawn from each of the three bottles with a micropipette immediately after preparation and 7, 15, 30, 60, and 90 days afterward. After further dilution to an expected concentration of 50 μg/mL with sample diluent, the samples were assayed in duplicate by stability-indicating high-performance liquid chromatography. The samples were visually examined for any color change and evaluated for pH on each day of analysis. Taste evaluations were performed at the beginning and end of the study. Stability was defined as the retention of at least 90% of the initial concentration. Results. At least 95% of the initial glycopyrrolate remained throughout the 90-day study period in both preparations. There were no detectable changes in color, odor, taste, and pH, and no visible microbial growth was observed in any sample. Conclusion. Extemporaneously compounded suspensions of glycopyrrolate 0.5 mg/mL in a 1:1 mixture of Ora-Plus/ Ora-Sweet or Ora-Plus/Ora-Sweet SF were stable for at least 90 days when stored in amber plastic bottles at room temperature.


Related Articles

  • EVALUATION OF ORAL ANTIBIOTIC UTILIZATION IN MEDICAL INPATIENTS. Jayakar, B.; Aleykutty, N. A.; Mathews, Santhosh M. // International Journal of Pharmacy & Pharmaceutical Sciences;Mar2012, Vol. 4 Issue 2, p304 

    The study was conducted to evaluate the effectiveness of regulations on antibiotic utilization after oral route of administration. It was performed before and after imposing regulations on antibiotics administration. The uses of all antibiotics were regulated using drug formulary and...

  • DEVELOPMENT AND EVALUATION OF ORAL RECONSTITUTABLE SYSTEMS OF CEPHALEXIN. Shanbhag, Pradnya Palekar; Bhalerao, S. S. // International Journal of PharmTech Research;Jan-Mar2010, Vol. 2 Issue 1, p502 

    Cephalexin, a cephalosporin antibiotic was chosen as the model drug candidate to obtain a dosage form with improved stability, palatability and attractive paediatric elegance, cost effective and with ease of administration. The present work was carried out to design and develop oral...

  • Stability of extemporaneously prepared oxandrolone oral suspensions. Johnson, Cary E.; Cober, Mary Petrea; Hawkins, Katherine A.; Julian, Justin D. // American Journal of Health-System Pharmacy;3/15/2011, Vol. 68 Issue 6, p519 

    Purpose. The stability of extemporaneously prepared oxandrolone oral suspensions was studied. Methods. Oxandrolone oral suspension (1 mg/mL) was prepared using oxandrolone tablets, Ora-Plus, and either Ora-Sweet or Ora-Sweet SF. Three identical samples of each formulation were prepared and...

  • Gradient HPLC-DAD Stability Indicating Determination of Miconazole Nitrate and Lidocaine Hydrochloride in their Combined Oral Gel Dosage Form. Belal, Tarek S.; Haggag, Rim S. // Journal of Chromatographic Science;May2012, Vol. 50 Issue 5, p401 

    The pharmaceutical combination of miconazole nitrate (MZ) and lidocaine hydrochloride (LD) is used in the curative and prophylactic therapy of the oral and gastro-intestinal infections caused by Candida albicans. To the best of our knowledge, no attempts have yet been made to assay this...

  • Stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus. Fohl, Alexander L.; Johnson, Cary E.; Cober, M. Petrea // American Journal of Health-System Pharmacy;1/1/2011, Vol. 68 Issue 1, p69 

    Purpose. The stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus was evaluated. Methods. Acetylcysteine 1% (10-mg/ mL) and 10% (100-mg/mL) solutions were prepared by mixing 3 and 10 mL, respectively, of commercially available 20%...

  • Diphenidol--A New Antiemetic. Lipschutz, Arthur; Fischer, Carl C. // Clinical Pediatrics;May1967, Vol. 6 Issue 5, p298 

    The paper provides information on diphenidol, antiemetic agent. Measures of control are chosen according to the type and severity of the vomiting, the state of health of the child, his medical history and other pertinent factors. Diphenidol is not a phenothiazine; it is...

  • Cogentin.  // Royal Society of Medicine: Medicines;2002, p167 

    The article presents information on cogentin which is a proprietary, prescription-only preparation of the anticholinergic benztropine mesilate. It can be used in the treatment of parkinsonism, and is available as tablets and in a form for injection.

  • Contimin.  // Royal Society of Medicine: Medicines;2002, p170 

    The article presents information on contimin which is a proprietary, prescription-only preparation of the anticholinergic oxybutynin hydrochloride. This drug can be used as an in the treatment of urinary disorders such as incontinence. It is available as tablets.

  • Detrunorm.  // Royal Society of Medicine: Medicines;2002, p194 

    This article presents information on the drug Detrunorm, a proprietary, prescription-only preparation of the anticholinergic propiverine hydrochloride. It can be used as an antispasmodic in the treatment of urinary disorders such as incontinence. It is available as tablets.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics